Anti-colorectal cancer effects of scutellarin revealed by genomic and proteomic analysis

Abstract Background Colorectal cancer, one of the most common digestive tumors with high mortality and morbidity worldwide, currently lacks effective therapies available to improve the prognosis. This study was aimed to investigate the potency of Scutellarin against colorectal cancers, and explore t...

Full description

Bibliographic Details
Main Authors: Liu-Lin Xiong, Ruo-Lan Du, Lu-Lu Xue, Ya Jiang, Jin Huang, Li Chen, Jia Liu, Ting-Hua Wang
Format: Article
Language:English
Published: BMC 2020-03-01
Series:Chinese Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13020-020-00307-z
id doaj-3b92ba4190214eb684f8deede875eae4
record_format Article
spelling doaj-3b92ba4190214eb684f8deede875eae42020-11-25T02:40:35ZengBMCChinese Medicine1749-85462020-03-0115111510.1186/s13020-020-00307-zAnti-colorectal cancer effects of scutellarin revealed by genomic and proteomic analysisLiu-Lin Xiong0Ruo-Lan Du1Lu-Lu Xue2Ya Jiang3Jin Huang4Li Chen5Jia Liu6Ting-Hua Wang7Institute of Neurological Disease, Translational Neuroscience Center, West China Hospital, Sichuan UniversityInstitute of Neurological Disease, Translational Neuroscience Center, West China Hospital, Sichuan UniversityAnimal Zoology Department, Institute of Neuroscience, Kunming Medical UniversityAnimal Zoology Department, Institute of Neuroscience, Kunming Medical UniversityAnimal Zoology Department, Institute of Neuroscience, Kunming Medical UniversityInstitute of Neurological Disease, Translational Neuroscience Center, West China Hospital, Sichuan UniversityAnimal Zoology Department, Institute of Neuroscience, Kunming Medical UniversityInstitute of Neurological Disease, Translational Neuroscience Center, West China Hospital, Sichuan UniversityAbstract Background Colorectal cancer, one of the most common digestive tumors with high mortality and morbidity worldwide, currently lacks effective therapies available to improve the prognosis. This study was aimed to investigate the potency of Scutellarin against colorectal cancers, and explore the related mechanism via genomic and proteomic analysis. Methods Cell counting kit-8 assay was employed to detect the viability of HCT-116 and RKO cell lines treated with Scutellarin. The apoptosis of HCT-116 and RKO cells after Scutellarin administration was determined by TUNEL staining and Caspase 3/7 activity. Cell cycle was detected by flow cytometry analysis. The wound healing and transwell invasion test detected the role of Scutellarin in migration and invasion of HCT-116 and RKO cells. Meanwhile, the energy metabolism and growth of tumor tissues in vivo at day 28 were observed by PET-CT after Scutellarin administration with 50 mg/kg, 100 mg/kg and 300 mg/kg into 4-week-old nude mice. Blood routine and liver functions were also detected to evaluate the side effect of Scutellarin. Furthermore, the disease and function classifications which the differentially expressed genes and proteins involved after Scutellarin treatment were determined by genomic and proteomic analysis respectively. Results The Scutellarin inhibited the migration and increased apoptosis of HCT-116 and RKO cell lines. Besides, Scutellarin treatment substantially decreased the growth and volume of colorectal tumors in nude mice without side effects on the blood routine and liver function. The differentially expressed genes in RKO cells after Scutellarin administration were mainly enriched in cell death and survival, organismal injury and abnormalities, and cancer. In addition, forty-seven upregulated and twenty-nine downregulated proteins were identified. Functional clustering analysis exhibited enriched biological processes, cellular components, molecular functions and related pathways of these proteins in cellular metabolic. Then protein–protein interactions analysis showed the regulatory relationship among these differentially expressed proteins. Conclusions Taken together, the present findings revealed that Scutellarin exerted significant antitumor effect with no side effects in the blood and liver by regulating various important molecules in tumor proliferation, apoptosis and metastasis.http://link.springer.com/article/10.1186/s13020-020-00307-zColorectal cancerScutellarinAntitumor effectGenomics, proteomics
collection DOAJ
language English
format Article
sources DOAJ
author Liu-Lin Xiong
Ruo-Lan Du
Lu-Lu Xue
Ya Jiang
Jin Huang
Li Chen
Jia Liu
Ting-Hua Wang
spellingShingle Liu-Lin Xiong
Ruo-Lan Du
Lu-Lu Xue
Ya Jiang
Jin Huang
Li Chen
Jia Liu
Ting-Hua Wang
Anti-colorectal cancer effects of scutellarin revealed by genomic and proteomic analysis
Chinese Medicine
Colorectal cancer
Scutellarin
Antitumor effect
Genomics, proteomics
author_facet Liu-Lin Xiong
Ruo-Lan Du
Lu-Lu Xue
Ya Jiang
Jin Huang
Li Chen
Jia Liu
Ting-Hua Wang
author_sort Liu-Lin Xiong
title Anti-colorectal cancer effects of scutellarin revealed by genomic and proteomic analysis
title_short Anti-colorectal cancer effects of scutellarin revealed by genomic and proteomic analysis
title_full Anti-colorectal cancer effects of scutellarin revealed by genomic and proteomic analysis
title_fullStr Anti-colorectal cancer effects of scutellarin revealed by genomic and proteomic analysis
title_full_unstemmed Anti-colorectal cancer effects of scutellarin revealed by genomic and proteomic analysis
title_sort anti-colorectal cancer effects of scutellarin revealed by genomic and proteomic analysis
publisher BMC
series Chinese Medicine
issn 1749-8546
publishDate 2020-03-01
description Abstract Background Colorectal cancer, one of the most common digestive tumors with high mortality and morbidity worldwide, currently lacks effective therapies available to improve the prognosis. This study was aimed to investigate the potency of Scutellarin against colorectal cancers, and explore the related mechanism via genomic and proteomic analysis. Methods Cell counting kit-8 assay was employed to detect the viability of HCT-116 and RKO cell lines treated with Scutellarin. The apoptosis of HCT-116 and RKO cells after Scutellarin administration was determined by TUNEL staining and Caspase 3/7 activity. Cell cycle was detected by flow cytometry analysis. The wound healing and transwell invasion test detected the role of Scutellarin in migration and invasion of HCT-116 and RKO cells. Meanwhile, the energy metabolism and growth of tumor tissues in vivo at day 28 were observed by PET-CT after Scutellarin administration with 50 mg/kg, 100 mg/kg and 300 mg/kg into 4-week-old nude mice. Blood routine and liver functions were also detected to evaluate the side effect of Scutellarin. Furthermore, the disease and function classifications which the differentially expressed genes and proteins involved after Scutellarin treatment were determined by genomic and proteomic analysis respectively. Results The Scutellarin inhibited the migration and increased apoptosis of HCT-116 and RKO cell lines. Besides, Scutellarin treatment substantially decreased the growth and volume of colorectal tumors in nude mice without side effects on the blood routine and liver function. The differentially expressed genes in RKO cells after Scutellarin administration were mainly enriched in cell death and survival, organismal injury and abnormalities, and cancer. In addition, forty-seven upregulated and twenty-nine downregulated proteins were identified. Functional clustering analysis exhibited enriched biological processes, cellular components, molecular functions and related pathways of these proteins in cellular metabolic. Then protein–protein interactions analysis showed the regulatory relationship among these differentially expressed proteins. Conclusions Taken together, the present findings revealed that Scutellarin exerted significant antitumor effect with no side effects in the blood and liver by regulating various important molecules in tumor proliferation, apoptosis and metastasis.
topic Colorectal cancer
Scutellarin
Antitumor effect
Genomics, proteomics
url http://link.springer.com/article/10.1186/s13020-020-00307-z
work_keys_str_mv AT liulinxiong anticolorectalcancereffectsofscutellarinrevealedbygenomicandproteomicanalysis
AT ruolandu anticolorectalcancereffectsofscutellarinrevealedbygenomicandproteomicanalysis
AT luluxue anticolorectalcancereffectsofscutellarinrevealedbygenomicandproteomicanalysis
AT yajiang anticolorectalcancereffectsofscutellarinrevealedbygenomicandproteomicanalysis
AT jinhuang anticolorectalcancereffectsofscutellarinrevealedbygenomicandproteomicanalysis
AT lichen anticolorectalcancereffectsofscutellarinrevealedbygenomicandproteomicanalysis
AT jialiu anticolorectalcancereffectsofscutellarinrevealedbygenomicandproteomicanalysis
AT tinghuawang anticolorectalcancereffectsofscutellarinrevealedbygenomicandproteomicanalysis
_version_ 1724780637342138368